938 related articles for article (PubMed ID: 15277330)
1. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
[TBL] [Abstract][Full Text] [Related]
2. Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway.
Tellier E; Nègre-Salvayre A; Bocquet B; Itohara S; Hannun YA; Salvayre R; Augé N
Mol Cell Biol; 2007 Apr; 27(8):2997-3007. PubMed ID: 17283058
[TBL] [Abstract][Full Text] [Related]
3. 7-Ketocholesterol and cholesterol-5alpha,6alpha-epoxide induce smooth muscle cell migration and proliferation through the epidermal growth factor receptor/phosphoinositide 3-kinase/Akt signaling pathways.
Liao PL; Cheng YW; Li CH; Wang YT; Kang JJ
Toxicol Lett; 2010 Aug; 197(2):88-96. PubMed ID: 20466046
[TBL] [Abstract][Full Text] [Related]
4. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.
Oak MH; El Bedoui J; Anglard P; Schini-Kerth VB
Circulation; 2004 Sep; 110(13):1861-7. PubMed ID: 15364805
[TBL] [Abstract][Full Text] [Related]
5. Letter regarding article by Augé et al., "Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation".
Izgi C; Cevik C; Ozkan M
Circulation; 2005 Feb; 111(4):e38-9; author reply e38-9. PubMed ID: 15687119
[No Abstract] [Full Text] [Related]
6. Oxidized LDL-induced smooth muscle cell proliferation involves the EGF receptor/PI-3 kinase/Akt and the sphingolipid signaling pathways.
Auge N; Garcia V; Maupas-Schwalm F; Levade T; Salvayre R; Negre-Salvayre A
Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):1990-5. PubMed ID: 12482824
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
Cirillo P; Calì G; Golino P; Calabrò P; Forte L; De Rosa S; Pacileo M; Ragni M; Scopacasa F; Nitsch L; Chiariello M
Circulation; 2004 Jun; 109(23):2911-6. PubMed ID: 15173027
[TBL] [Abstract][Full Text] [Related]
8. E-cadherin/beta-catenin/T-cell factor pathway is involved in smooth muscle cell proliferation elicited by oxidized low-density lipoprotein.
Bedel A; Nègre-Salvayre A; Heeneman S; Grazide MH; Thiers JC; Salvayre R; Maupas-Schwalm F
Circ Res; 2008 Sep; 103(7):694-701. PubMed ID: 18703780
[TBL] [Abstract][Full Text] [Related]
9. MAO-A-induced mitogenic signaling is mediated by reactive oxygen species, MMP-2, and the sphingolipid pathway.
Coatrieux C; Sanson M; Negre-Salvayre A; Parini A; Hannun Y; Itohara S; Salvayre R; Auge N
Free Radic Biol Med; 2007 Jul; 43(1):80-9. PubMed ID: 17561096
[TBL] [Abstract][Full Text] [Related]
10. Plasmin-induced smooth muscle cell proliferation requires epidermal growth factor activation through an extracellular pathway.
Roztocil E; Nicholl SM; Galaria II; Davies MG
Surgery; 2005 Aug; 138(2):180-6. PubMed ID: 16153425
[TBL] [Abstract][Full Text] [Related]
11. Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase Inducer (EMMPRIN) release by coronary smooth muscle cells.
Haug C; Lenz C; Díaz F; Bachem MG
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1823-9. PubMed ID: 15319264
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the 92-kDa gelatinase (matrix metalloproteinase-9) in the ceramide-mediated inhibition of human keratinocyte growth.
Buisson-Legendre N; Bernard P; Bobichon H; Emonard H; Schneider C; Maquart FX; Haye B; Hornebeck W
Biochem Biophys Res Commun; 1999 Jul; 260(3):634-40. PubMed ID: 10403818
[TBL] [Abstract][Full Text] [Related]
13. Chemokines induce matrix metalloproteinase-2 through activation of epidermal growth factor receptor in arterial smooth muscle cells.
Kodali R; Hajjou M; Berman AB; Bansal MB; Zhang S; Pan JJ; Schecter AD
Cardiovasc Res; 2006 Feb; 69(3):706-15. PubMed ID: 16343467
[TBL] [Abstract][Full Text] [Related]
14. Remnant lipoprotein-induced smooth muscle cell proliferation involves epidermal growth factor receptor transactivation.
Kawakami A; Tanaka A; Chiba T; Nakajima K; Shimokado K; Yoshida M
Circulation; 2003 Nov; 108(21):2679-88. PubMed ID: 14623816
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells.
Nagata T; Kai H; Shibata R; Koga M; Yoshimura A; Imaizumi T
Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):588-93. PubMed ID: 12615664
[TBL] [Abstract][Full Text] [Related]
16. The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator.
Maupas-Schwalm F; Augé N; Robinet C; Cambus JP; Parsons SJ; Salvayre R; Nègre-Salvayre A
FASEB J; 2004 Sep; 18(12):1398-400. PubMed ID: 15231724
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration.
Galaria II; Fegley AJ; Nicholl SM; Roztocil E; Davies MG
J Surg Res; 2004 Dec; 122(2):173-9. PubMed ID: 15555614
[TBL] [Abstract][Full Text] [Related]
18. Potential role for ceramide in mitogen-activated protein kinase activation and proliferation of vascular smooth muscle cells induced by oxidized low density lipoprotein.
Augé N; Escargueil-Blanc I; Lajoie-Mazenc I; Suc I; Andrieu-Abadie N; Pieraggi MT; Chatelut M; Thiers JC; Jaffrézou JP; Laurent G; Levade T; Nègre-Salvayre A; Salvayre R
J Biol Chem; 1998 May; 273(21):12893-900. PubMed ID: 9582320
[TBL] [Abstract][Full Text] [Related]
19. Oxidized low-density lipoprotein retards the growth of proliferating cells by inhibiting nuclear translocation of cell cycle proteins.
Zettler ME; Prociuk MA; Austria JA; Zhong G; Pierce GN
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):727-32. PubMed ID: 14764420
[TBL] [Abstract][Full Text] [Related]
20. A key role for matrix metalloproteinases and neutral sphingomyelinase-2 in transplant vasculopathy triggered by anti-HLA antibody.
Galvani S; Trayssac M; Augé N; Thiers JC; Calise D; Krell HW; Sallusto F; Kamar N; Rostaing L; Thomsen M; Nègre-Salvayre A; Salvayre R
Circulation; 2011 Dec; 124(24):2725-34. PubMed ID: 22082680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
